| #200 |
Mark Francis Lucien Harper |
Bp Corporation North America |
1 |
| #200 |
Yoram Bachrach |
Microsoft |
1 |
| #200 |
Chiloda Ashan Senerath Pathirane |
NVIDIA |
1 |
| #200 |
Joanna Krystyna Skiba-Szymanska |
Kabushiki Kaisha Toshiba |
1 |
| #200 |
Wesley Blackaby |
Merck |
1 |
| #200 |
David Livermore |
Glaxo Group Limited |
1 |
| #200 |
Paul Graham Wilkins |
Bedford Systems |
1 |
| #200 |
Lukasz Kurzepa |
Cambridge Enterprise Limited |
1 |
| #200 |
Krzysztof Kazimierz Koziol |
Cambridge Enterprise Limited |
1 |
| #200 |
Simon Roderick Grover |
Covidien Lp |
1 |
| #200 |
Andrey Alexandrovich Arzumanov |
Medical Research Council |
1 |
| #200 |
Benjamin Whalley |
Gw Research Limited |
1 |
| #200 |
Adrian Stacey |
The Automation Partnership (Cambridge) Limited |
1 |
| #200 |
Andrew Macleod |
Bayer Oy |
1 |
| #200 |
Sarah Joanne Aves |
Heptares Therapeutics Limited |
1 |
| #200 |
Antony Rix |
British Telecommunications Public Limited |
1 |
| #200 |
Gianni Chessari |
Astex Therapeutics Limited |
1 |
| #200 |
Daniel Paul Teufel |
Bicyclerd Limited |
1 |
| #200 |
John Andrew Christopher |
Heptares Therapeutics Limited |
1 |
| #200 |
Fraser Welsh |
Medimmune Limited |
1 |
| #200 |
Martin Cvetanov Marinov |
Broadcom |
1 |
| #200 |
Harry Finch |
Glaxo Group Limited |
1 |
| #200 |
Jonathan David Tuckwell |
Oriel Therapeutics |
1 |
| #200 |
Thomas John Hector Copeland |
Covidien Lp |
1 |
| #200 |
David Cebon |
Cambridge Enterprise Limited |
1 |
| #200 |
Wladyslaw Wygnanski |
Camcon Limited |
1 |
| #200 |
Alexander Gutkin |
Google |
1 |
| #200 |
Vincenzo Martinelli |
Euro-Celtique S.A. |
1 |
| #200 |
Roderick Andrew Haines |
Cadbury Uk Limited |
1 |
| #200 |
Leon M. Henderson |
Cambridge Enterprise Limited |
1 |
| #200 |
Simon Philip Kingsley |
Antenova Limited |
1 |
| #200 |
Gareth John CONDUIT |
Rolls-Royce Plc |
1 |
| #200 |
Mark Robert Gabriel Douglas |
Koniniklijke Philips N.V. |
1 |
| #200 |
Sohini Kar-Narayan |
CEA |
1 |
| #200 |
Simon Peyton-Jones |
— |
1 |
| #200 |
Robert KIRBY |
Allelix Biopharmaceuticals |
1 |
| #200 |
Thomas Owen Parry |
Blackberry Limited |
1 |
| #200 |
Willem Paul Beeker |
Philip Morris Products S.A. |
1 |
| #200 |
Christopher Zach |
Kabushiki Kaisha Toshiba |
1 |
| #200 |
Dall G. Amos |
C.R. Bard |
1 |
| #200 |
Arthur Keith Turner |
Acambis Research Limited |
1 |
| #200 |
Andrew Southgate |
Bromium |
1 |
| #200 |
Anthony John Bennett |
Kabushiki Kaisha Toshiba |
1 |
| #200 |
Catherine Huntington |
Medimmune Limited |
1 |
| #200 |
Ludovic Sylvain Marc RENOU |
Infinity Pharmaceuticals |
1 |
| #200 |
Peter William Harris |
NVIDIA |
1 |
| #200 |
Robert George Boyle |
Sentinel Oncology Limited |
1 |
| #200 |
Man Kuan Chan |
Cambridge Enterprise Limited |
1 |
| #200 |
Atta Ur Rehman |
Oracle |
1 |
| #200 |
Cathal Joseph McElgunn |
Roche Molecular Systems |
1 |